Physician

Antoine Hage, MD

According to 2025 Medicare claims, Antoine Hage, MD (NPI: 1467540203) practices advanced heart failure and transplant cardiology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is CEDARS-SINAI MEDICAL CARE FOUNDATION (NPI: 1316984388; TIN: 954457756) and primary practice location at 90211-2930.

Hage's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 487 traditional Medicare patients, billed 1,504 HCPCS/CPT codes, and received $115,545 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 3,561 prescription claims across 370 beneficiaries totaling $4,163,584 in drug costs, led by Uptravi (Selexipag). DME data shows 187 claims. Open Payments data shows 6 records totaling $277,355. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $898,740 to $4,163,584. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $8,399 and ending at $13,492.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	495	1,756	$114,370
2016	475	1,808	$111,966
2017	481	1,763	$126,661
2018	471	1,659	$108,866
2019	484	1,828	$119,503
2020	403	1,271	$78,676
2021	461	1,481	$113,879
2022	496	1,495	$110,728
2023	512	1,624	$116,848
2024	487	1,504	$115,545

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	222	3,230	$898,740
2016	232	3,181	$1,666,437
2017	251	3,258	$2,823,555
2018	252	3,150	$2,946,734
2019	268	3,177	$1,918,701
2020	281	3,374	$2,451,876
2021	289	3,210	$2,480,471
2022	317	3,179	$2,438,423
2023	332	3,486	$5,193,005
2024	370	3,561	$4,163,584

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	60	$7,419
2016	N/R	57	$124,928
2017	N/R	97	$37,622
2018	N/R	27	$1,511
2019	N/R	130	$300,622
2020	N/R	184	$421,783
2021	N/R	134	$365,220
2022	N/R	146	$497,539
2023	N/R	119	$387,717
2024	N/R	187	$240,289

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	46	46	$178
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	312	479	$146
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	144	193	$92
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	153	175	$12
36415	Insertion of needle into vein for collection of blood sample	151	249	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Uptravi	Selexipag	65	1,992	$1,175,975
Tyvaso Dpi	Treprostinil	35	980	$789,285
Opsumit	Macitentan	40	1,200	$495,968
Vyndamax	Tafamidis	15	450	$388,689
Adempas	Riociguat	30	870	$384,911

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7686	Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg	N	N/R	14	$228,688
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	80	$5,591
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	12	$3,349
E1392	Portable oxygen concentrator, rental	Y	N/R	56	$1,902
K0738	Portable gaseous oxygen system, rental; home compressor used to fill portable oxygen cylinders; includes portable containers, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	12	$423

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$54	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$277,301	Cedars-Sinai Medical Center
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Antoine Hage, MD?

Tedicare shows public-source Medicare data for Antoine Hage, MD (NPI 1467540203), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Antoine Hage, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Antoine Hage, MD?

Antoine Hage, MD is linked to CEDARS-SINAI MEDICAL CARE FOUNDATION (billing NPI 1316984388) in the available physician profile data.

Does Antoine Hage, MD have Open Payments data?

Antoine Hage, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.